Literature DB >> 29572723

Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.

Alexandre Vallée1,2, Yves Lecarpentier3, Rémy Guillevin4, Jean-Noël Vallée5,6.   

Abstract

Entropy production rate is increased by several metabolic and thermodynamics abnormalities in neurodegenerative diseases (NDs). Irreversible processes are quantified by changes in the entropy production rate. This review is focused on the opposing interactions observed in NDs between the canonical WNT/beta-catenin pathway and PPAR gamma and their metabolic and thermodynamic implications. In amyotrophic lateral sclerosis and Huntington's disease, WNT/beta-catenin pathway is upregulated, whereas PPAR gamma is downregulated. In Alzheimer's disease and Parkinson's disease, WNT/beta-catenin pathway is downregulated while PPAR gamma is upregulated. The dysregulation of the canonical WNT/beta-catenin pathway is responsible for the modification of thermodynamics behaviors of metabolic enzymes. Upregulation of WNT/beta-catenin pathway leads to aerobic glycolysis, named Warburg effect, through activated enzymes, such as glucose transporter (Glut), pyruvate kinase M2 (PKM2), pyruvate dehydrogenase kinase 1(PDK1), monocarboxylate lactate transporter 1 (MCT-1), lactic dehydrogenase kinase-A (LDH-A) and inactivation of pyruvate dehydrogenase complex (PDH). Downregulation of WNT/beta-catenin pathway leads to oxidative stress and cell death through inactivation of Glut, PKM2, PDK1, MCT-1, LDH-A but activation of PDH. In addition, in NDs, PPAR gamma is dysregulated, whereas it contributes to the regulation of several key circadian genes. NDs show many dysregulation in the mediation of circadian clock genes and so of circadian rhythms. Thermodynamics rhythms operate far-from-equilibrium and partly regulate interactions between WNT/beta-catenin pathway and PPAR gamma. In NDs, metabolism, thermodynamics and circadian rhythms are tightly interrelated.

Entities:  

Keywords:  Aerobic glycolysis; Circadian rhythms; Neurodegenerative diseases; Oxidative stress; PPAR gamma; WNT/beta-catenin pathway

Mesh:

Substances:

Year:  2018        PMID: 29572723     DOI: 10.1007/s12017-018-8486-x

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  417 in total

1.  Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Alzheimers Dis       Date:  2006-07       Impact factor: 4.472

Review 2.  Hypothalamic and neuroendocrine changes in Huntington's disease.

Authors:  Sofia Hult; Kristofer Schultz; Rana Soylu; A Petersén
Journal:  Curr Drug Targets       Date:  2010-10       Impact factor: 3.465

Review 3.  Huntington's Disease.

Authors:  Steven Finkbeiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

4.  Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease.

Authors:  A Jennifer Morton; Nigel I Wood; Michael H Hastings; Carrie Hurelbrink; Roger A Barker; Elizabeth S Maywood
Journal:  J Neurosci       Date:  2005-01-05       Impact factor: 6.167

Review 5.  Sleep and Alzheimer disease pathology--a bidirectional relationship.

Authors:  Yo-El S Ju; Brendan P Lucey; David M Holtzman
Journal:  Nat Rev Neurol       Date:  2013-12-24       Impact factor: 42.937

Review 6.  Wnt signaling in Alzheimer's disease: up or down, that is the question.

Authors:  Rick A C M Boonen; Paula van Tijn; Danica Zivkovic
Journal:  Ageing Res Rev       Date:  2008-12-03       Impact factor: 10.895

7.  Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway.

Authors:  Ki Sook Park; Rhee Da Lee; Sun-Kyung Kang; Soon Young Han; Kui Lae Park; Ki Hwa Yang; Youn Sook Song; Hye Ji Park; Yoot Mo Lee; Yeo Pyo Yun; Ki Wan Oh; Dae Joong Kim; Young Won Yun; Se Jin Hwang; Sung Eun Lee; Jin Tae Hong
Journal:  Exp Cell Res       Date:  2004-07-15       Impact factor: 3.905

8.  Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function.

Authors:  C Ciron; S Lengacher; J Dusonchet; P Aebischer; B L Schneider
Journal:  Hum Mol Genet       Date:  2012-01-12       Impact factor: 6.150

Review 9.  PPARγ and PGC-1α as therapeutic targets in Parkinson's.

Authors:  Juan Carlos Corona; Michael R Duchen
Journal:  Neurochem Res       Date:  2014-07-10       Impact factor: 3.996

Review 10.  Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon Cancer.

Authors:  Yves Lecarpentier; Victor Claes; Alexandre Vallée; Jean-Louis Hébert
Journal:  PPAR Res       Date:  2017-02-19       Impact factor: 4.964

View more
  17 in total

Review 1.  WNT/β-catenin Pathway: a Possible Link Between Hypertension and Alzheimer's Disease.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Yves Lecarpentier
Journal:  Curr Hypertens Rep       Date:  2022-07-05       Impact factor: 4.592

Review 2.  Arterial Stiffness and the Canonical WNT/β-catenin Pathway.

Authors:  Alexandre Vallée
Journal:  Curr Hypertens Rep       Date:  2022-06-21       Impact factor: 4.592

Review 3.  Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Mol Psychiatry       Date:  2021-04-09       Impact factor: 15.992

Review 4.  Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Int J Mol Sci       Date:  2018-04-16       Impact factor: 5.923

Review 5.  Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Cells       Date:  2019-07-15       Impact factor: 6.600

Review 6.  Circadian Rhythms in Exudative Age-Related Macular Degeneration: The Key Role of the Canonical WNT/β-Catenin Pathway.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rodolphe Vallée; Rémy Guillevin; Jean-Noël Vallée
Journal:  Int J Mol Sci       Date:  2020-01-27       Impact factor: 5.923

7.  Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Rémy Guillevin; Yves Lecarpentier
Journal:  Aging (Albany NY)       Date:  2020-02-08       Impact factor: 5.682

Review 8.  Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Cells       Date:  2020-01-28       Impact factor: 6.600

Review 9.  PPARγ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/β-catenin pathway.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Yves Lecarpentier
Journal:  Mol Psychiatry       Date:  2018-08-13       Impact factor: 15.992

Review 10.  Opposed Interplay between IDH1 Mutations and the WNT/β-Catenin Pathway: Added Information for Glioma Classification.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Biomedicines       Date:  2021-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.